Recent advancements in nuclear medicine, particularly in personalised radiopharmaceutical therapy, have emphasised the growing need for precise assessments of therapeutic safety and efficacy. These evaluations depend heavily on individual patient pharmacokinet... ...

请注册登录后继续浏览